**Specifications Table**TableSubject areaWater Resources and Environmental EngineeringMore specific subject areaSurface Water Quality and health-risk assessmentType of dataTables and figureHow data was acquiredRiver visits, Samples were collected during the wet season into a high density polyethene containers, ionic concentration analysis using standard methods [@bib1], Inductively coupled plasma optical emission spectrophotometer (ICP-OES) for metal detection.Data formatFiltered, analyzedExperimental factorsMeasuring the values of heavy metal ion content of surface water samples. Calculating the human health risk assessment after the concentration of heavy metals were obtained.Experimental featuresDetermining the possible concentration levels of some selected Heavy Metals in River water samples at specific points were inhabitants collect water for various uses. Samples collected were preserved as stipulated by standard. After which, proper analysis was carried out.Data source locationAdodo-Ota, Ogun State, Nigeria. Latitude 6°40′58.52′′N-6°41′23.92′′N and Longitude 3°8′53.87′′E - 3°8′57.86′′E.Related research articleThe data are available with this article

**Value of the data**●The presence of Heavy Metals in surface water is unavoidable especially with the growing concerns of indiscriminate release of untreated effluent by industries within the study area. To this end, there are likelihood of adverse effects on Humans when consumed either in little or large quantities. This data obtained revealed the contamination levels of some selected Heavy Metals.●The associated health risk is pertinent considering various means by which these Heavy Metals find their way into the body.●The associated health risk for different age groups and population is required to estimate the at-risk groups among them for proper intervention from both Governmental and non-Governmental Organizations.●The data is required for the design and implementation of essential and accurate treatment technique(s) for industrial effluents as well as agrochemicals that might have polluted the river.

1. Data {#s0005}
=======

The data presented showed the concentration levels of selected surface water quality obtained from River Balogun in Adodo-Ota, Ogun State and the associated health risk due to oral consumption only. The presence of these heavy metals emerged due to presence of many industries situated close to the river and consistently discharged untreated liquid waste into the river under study which affected the water quality adversely [@bib2]. This calls for investigations of both the dispersive properties and toxicity levels of these contaminants as the river were mostly utilized by dwellers downstream unconsciously [@bib3]. [Fig. 1](#f0005){ref-type="fig"} exposes several points along the river where samples were collected with locations between latitude 6°40′58.52′′N--6°41′23.92′′N and longitude 3°8′53.87′′E--3°8′57.86′′E, having an area of 1460 km^2^ [@bib4].Fig. 1Map of study area showing sampling locations.Fig. 1

2. Experimental design, materials, and methods {#s0010}
==============================================

Seventeen (17) sampling points were assessed and a total of fifty-one samples were collected. The samples were preserved with acid and kept in a cooler to prevent speciation of the inherent metals. Thereafter, the mean values obtained from each sampling stations were used to calculate the associated health risk and comparison with standard values to ascertain whether or not these values were in concentrations below or above limits set by World Health Organization [@bib5].

In this study, samples collected were obtained from sections of the river where inhabitants of the locality get water for various uses especially farmers. Additionally, some essential physicochemical properties of water such as pH, Total dissolved solids (TDS), Electrical Conductivity (EC) and Temperature were measured using HANNA -- HI2030 device before taking collected samples for heavy metal analysis. Other heavy metals reported in this study were achieved using the Inductively coupled plasma optical emission spectrophotometer (ICP-OES). The raw values obtained from the analysis of the sampled surface water are presented in [Table 1](#t0005){ref-type="table"}.Table 1Individual metal concentration of analyzed river water samples (*N*^d^=51 from 17 different locations).Table 1*Station ID*Cu (mg/L)Zn (mg/L)Ni (mg/L)Cr (mg/L)Cd (mg/L)Pb (mg/L)As (mg/L)ST10.080.200.03NDND0.000.04ST20.080.110.03NDND0.000.04ST30.070.100.03NDND0.000.05ST40.060.230.01NDND0.010.05ST50.050.210.01NDND0.010.05ST60.050.240.01NDND0.010.05ST70.060.140.01NDND0.000.04ST80.060.220.01NDND0.000.03ST90.060.130.01NDND0.000.03ST100.060.330.02NDND0.000.03ST110.060.790.02NDND0.000.03ST120.060.290.02NDND0.000.05ST130.070.440.02NDND0.000.03ST140.070.510.02NDND0.000.04ST150.070.390.03NDND0.000.06ST160.070.530.03NDND0.000.06ST170.070.300.03NDND0.000.08ST180.050.450.01NDND0.010.05ST190.050.530.01NDND0.010.05

Consequently, these values obtained ([Table 1](#t0005){ref-type="table"}) can be used to determine the consumption of these metals on a daily basis. In addition, the overall daily consumption or accumulation were determined with other variables known to be key parameters for the calculation of risk due to ingestion of contaminated water from this region. For instance, the concentration of various elements used for this analysis were obtained from estimating the level of contamination in water by laboratory analysis (Cfw), while the ingestion rate (IRw), frequency at which the individual is expected to be exposed to these contaminants (EFr), duration of exposure (ED), body weight (BW) and average time (ATr) were varied for children to adulthood from 6 to 12 months, 6 to 11 years, 11 to 16 years, 16 to 18 years, 18 to 21 years, ≥ 21 years and above 65 years [@bib6]. Specifically, ingestion rate (IRw) values in L/day were 1, 1.32, 1.82, 1.78, 2.34, 2.94 and 2.73 for the different age groups mentioned respectively [@bib6], Exposure frequency (EFr) measured in days/year were constant at 365 for all age groups [@bib6], Exposure duration (ED) in years were constant at 6 for the first four age groups and also constant at 20 for the last three age groups [@bib7]. Another parameter that varied as explained were the body weight of the different categories. The body weight (kg) varied at 9.1, 29.3, 54.2, 67.6, 67.6, 78.8 and 80 [@bib6] and finally, average time (ATr) in Days was constant at 2190 for the first four age groups and also constant at 7300 for the last three age groups as well [@bib6].The values presented in [Table 2](#t0010){ref-type="table"} are in accordance with laid down models or equations approved by United States Environmental Protection Agency (USEPA) and have been used in several studies in the literature [@bib6], [@bib8], [@bib9], [@bib10], [@bib11] for estimating the chronic daily dose (CDD) or average daily dose (ADD) of heavy metals measured in mg/kg/day. The values obtained through laboratory analysis (see [Table 1](#t0005){ref-type="table"}) are inputted into Eqs. [(1)](#eq0005){ref-type="disp-formula"} and [(2)](#eq0010){ref-type="disp-formula"} to estimate the associated risk from the consumption of surface water from River Balogun through ingestion route with focus on children and adult [@bib12], [@bib13] of diverse age groups resulting from variability in body mass index. This was required because different body weight are susceptible to different risk intensity [@bib9]$$ADD_{IN} = \frac{C_{fw} \times IR_{w} \times EF_{r} \times ED}{BW \times AT_{r}}$$Table 2Oral reference dose (RfD).Table 2MetalsRfD ingestion (mg/kg/day)Arsenic (As)3.00E−4Copper (Cu)3.70E−2Nickel (Ni)2.00E−2Zinc (Zn)3.00E−01Lead (Pb)3.50E−03[^1]

Specifically, [Table 2](#t0010){ref-type="table"}, [Table 3a](#t0015){ref-type="table"}, [Table 3b](#t0020){ref-type="table"}, [Table 4a](#t0025){ref-type="table"}, [Table 4b](#t0030){ref-type="table"}, [Table 5a](#t0035){ref-type="table"}, [Table 5b](#t0040){ref-type="table"}, [Table 6a](#t0045){ref-type="table"}(a) revealed the CDD ingestion values for the metals analyzed which were estimated with Eq. [(1)](#eq0005){ref-type="disp-formula"} while [Table 2](#t0010){ref-type="table"}, [Table 3a](#t0015){ref-type="table"}, [Table 3b](#t0020){ref-type="table"}, [Table 4a](#t0025){ref-type="table"}, [Table 4b](#t0030){ref-type="table"}, [Table 5a](#t0035){ref-type="table"}, [Table 5b](#t0040){ref-type="table"}, [Table 6a](#t0045){ref-type="table"}(b) showed the potentiality of a risk for the different population at different age groups overtime which were also estimated using Eq. [(2)](#eq0010){ref-type="disp-formula"} [@bib14].$$HRI_{IN} = \frac{ADD_{IN}}{RfD_{metal}}$$Table 3aAverage daily dose (ADD) via ingestion pathway for Cu concentration.Table 3a:**Cu ADD**~**IN**~**values***Station ID*(6--12 months)(6--11 years)(11--16 years)(16--18 years)(18--21 years)(≥21 years)(\>65 years)ST18.7913.6042.6862.1072.7692.9852.730ST28.4623.4692.5862.0282.6652.8732.628ST38.1323.3342.4851.9492.5622.7612.525ST46.2642.5681.9141.5011.9732.1271.945ST55.9342.4331.8131.4221.8692.0151.843ST65.9342.4331.8131.4221.8692.0151.843ST76.1542.5231.8801.4751.9382.0891.911ST86.2642.5681.9141.5011.9732.1271.945ST96.3742.6131.9481.5272.0082.1641.979ST106.4842.6581.9811.5542.0422.2012.013ST116.5932.7032.0151.5802.0772.2392.048ST126.9232.8382.1151.6592.1812.3512.150ST137.1432.9282.1831.7122.2502.4252.218ST147.1432.9282.1831.7122.2502.4252.218ST157.2532.9732.2161.7382.2852.4622.252ST167.4733.0632.2831.7912.3542.5372.321ST177.3633.0182.2501.7642.3192.5002.286Table 3bHealth Risk Index (HRI) via ingestion pathway for Cu concentration.Table 3b:**Cu HRI**~**IN**~**values***Station ID*(6--12 months)(6--11 years)(11--16 years)(16--18 years)(18--21 years)(≥21 years)(\>65 years)ST19.010E−026.716E−025.266E−026.923E−027.462E−022.198E−016.825E−02ST28.672E−026.464E−025.069E−026.663E−027.182E−022.115E−016.569E−02ST38.334E−026.212E−024.871E−026.404E−026.902E−022.033E−016.313E−02ST46.420E−024.785E−023.752E−024.933E−025.317E−021.566E−014.863E−02ST56.082E−024.533E−023.555E−024.673E−025.037E−021.484E−014.607E−02ST66.082E−024.533E−023.555E−024.673E−025.037E−021.484E−014.607E−02ST76.307E−024.701E−023.686E−024.846E−025.223E−021.538E−014.778E−02ST86.420E−024.785E−023.752E−024.933E−025.317E−021.566E−014.863E−02ST96.532E−024.869E−023.818E−025.019E−025.410E−021.593E−014.948E−02ST106.645E−024.953E−023.884E−025.106E−025.503E−021.621E−015.033E−02ST116.758E−025.037E−023.950E−025.192E−025.596E−021.648E−015.119E−02ST127.096E−025.289E−024.147E−025.452E−025.876E−021.731E−015.375E−02ST137.321E−025.457E−024.279E−025.625E−026.063E−021.786E−015.545E−02ST147.321E−025.457E−024.279E−025.625E−026.063E−021.786E−015.545E−02ST157.433E−025.541E−024.345E−025.712E−026.156E−021.813E−015.631E−02ST167.659E−025.708E−024.476E−025.885E−026.343E−021.868E−015.801E−02ST177.546E−025.625E−024.411E−025.798E−026.249E−021.841E−015.716E−02Table 4aAverage daily dose (ADD) via ingestion pathway for Zn concentration.Table 4a:**Zn ADD**~**IN**~**values***Station ID*(6--12 months)(6--11 years)(11--16 years)(16--18 years)(18--21 years)(≥21 years)(\>65 years)ST121.8418.9546.6745.2336.8807.4156.782ST211.9914.9163.6642.8733.7774.0713.724ST310.7734.4163.2922.5813.3933.6573.345ST425.58110.4877.8176.1308.0588.6857.944ST523.0859.4647.0545.5317.2727.8387.169ST626.83311.0018.1996.4308.4529.1108.333ST715.6646.4224.7863.7534.9345.3184.864ST824.3319.9757.4355.8307.6648.2617.556ST914.4375.9194.4123.4594.5484.9024.483ST1036.70315.04711.2158.79511.56112.46111.398ST1186.42835.43326.41020.71027.22529.34426.839ST1231.69312.9939.6847.5949.98310.7609.842ST1348.13219.73214.70811.53315.16216.34214.947ST1455.87122.90517.07313.38817.59918.96917.350ST1543.02617.63913.14710.31013.55314.60813.361ST1658.47223.97217.86714.01118.41919.85218.158ST1732.94113.50510.0667.89310.37711.18410.230Table 4bHealth Risk Index (HRI) via ingestion pathway for Zn concentration.Table 4b:**Zn HRI**~**IN**~**values***Station ID*(6--12 months)(6--11 years)(11--16 years)(16--18 years)(18--21 years)(≥21 years)(\>65 years)ST12.985E−022.225E−021.744E−022.293E−022.472E−027.280E−022.261E−02ST21.639E−021.221E−029.578E−031.259E−021.357E−023.997E−021.241E−02ST31.472E−021.097E−028.604E−031.131E−021.219E−023.591E−021.115E−02ST43.496E−022.606E−022.043E−022.686E−022.895E−028.527E−022.648E−02ST53.155E−022.351E−021.844E−022.424E−022.613E−027.695E−022.390E−02ST63.667E−022.733E−022.143E−022.817E−023.037E−028.944E−022.778E−02ST72.141E−021.595E−021.251E−021.645E−021.773E−025.221E−021.621E−02ST83.325E−022.478E−021.943E−022.555E−022.754E−028.110E−022.519E−02ST91.973E−021.471E−021.153E−021.516E−021.634E−024.812E−021.494E−02ST105.016E−023.738E−022.932E−023.854E−024.154E−021.223E−013.799E−02ST111.181E−018.803E−026.903E−029.075E−029.781E−022.881E−018.946E−02ST124.331E−023.228E−022.531E−023.328E−023.587E−021.056E−013.281E−02ST136.577E−024.903E−023.844E−025.054E−025.447E−021.604E−014.982E−02ST147.635E−025.691E−024.463E−025.866E−026.323E−021.862E−015.783E−02ST155.880E−024.382E−023.437E−024.518E−024.869E−021.434E−014.454E−02ST167.991E−025.956E−024.670E−026.140E−026.617E−021.949E−016.053E−02ST174.502E−023.355E−022.631E−023.459E−023.728E−021.098E−013.410E−02Table 5aAverage daily dose (ADD) via ingestion pathway for Ni concentration.Table 5a:**Ni ADD**~**IN**~**values***Station ID*(6--12 months)(6--11 years)(11--16 years)(16--18 years)(18--21 years)(≥21 years)(\>65 years)ST12.7471.1260.8390.6580.8650.9330.853ST23.1871.3060.9740.7641.0041.0820.990ST33.5161.4421.0750.8431.1081.1941.092ST40.5490.2250.1680.1320.1730.1870.171ST50.6590.2700.2010.1580.2080.2240.205ST60.7690.3150.2350.1840.2420.2610.239ST71.0990.4510.3360.2630.3460.3730.341ST81.3190.5410.4030.3160.4150.4480.410ST91.5380.6310.4700.3690.4850.5220.478ST101.7580.7210.5370.4210.5540.5970.546ST111.9780.8110.6040.4740.6230.6720.614ST122.1980.9010.6720.5270.6920.7460.683ST132.5271.0360.7720.6060.7960.8580.785ST142.6371.0810.8060.6320.8310.8950.819ST153.0771.2610.9400.7370.9691.0450.956ST163.2971.3521.0070.7901.0381.1191.024ST173.5161.4421.0750.8431.1081.1941.092Table 5bHealth Risk Index (HRI) via ingestion pathway for Ni concentration.Table 5b:**Ni HRI**~**IN**~**values***Station ID*(6--12 months)(6--11 years)(11--16 years)(16--18 years)(18--21 years)(≥21 years)(\>65 years)ST15.631E−024.197E−023.291E−024.327E−024.664E−021.374E−014.266E−02ST26.532E−024.869E−023.818E−025.019E−025.410E−021.593E−014.948E−02ST37.208E−025.373E−024.213E−025.538E−025.970E−021.758E−015.460E−02ST41.126E−028.395E−036.583E−038.654E−039.327E−032.747E−028.531E−03ST51.352E−021.007E−027.899E−031.038E−021.119E−023.297E−021.024E−02ST61.577E−021.175E−029.216E−031.212E−021.306E−023.846E−021.194E−02ST72.253E−021.679E−021.317E−021.731E−021.865E−025.495E−021.706E−02ST82.703E−022.015E−021.580E−022.077E−022.239E−026.593E−022.048E−02ST93.154E−022.351E−021.843E−022.423E−022.612E−027.692E−022.389E−02ST103.604E−022.686E−022.107E−022.769E−022.985E−028.791E−022.730E−02ST114.055E−023.022E−022.370E−023.115E−023.358E−029.890E−023.071E−02ST124.505E−023.358E−022.633E−023.462E−023.731E−021.099E−013.413E−02ST135.181E−023.862E−023.028E−023.981E−024.291E−021.264E−013.924E−02ST145.406E−024.030E−023.160E−024.154E−024.477E−021.319E−014.095E−02ST156.307E−024.701E−023.686E−024.846E−025.223E−021.538E−014.778E−02ST166.758E−025.037E−023.950E−025.192E−025.596E−021.648E−015.119E−02ST177.208E−025.373E−024.213E−025.538E−025.970E−021.758E−015.460E−02Table 6aAverage daily dose (ADD) via ingestion pathway for As concentration.Table 6a:**As ADD**~**IN**~**values***Station ID*(6--12 months)(6--11 years)(11--16 years)(16--18 years)(18--21 years)(≥21 years)(\>65 years)ST14.0661.6671.2420.9741.2811.3801.263ST24.0661.6671.2420.9741.2811.3801.263ST35.8242.3881.7801.3961.8351.9771.809ST45.8242.3881.7801.3961.8351.9771.809ST55.3852.2081.6451.2901.6961.8281.672ST65.1652.1171.5781.2381.6271.7541.604ST74.3961.8021.3431.0531.3851.4921.365ST83.6261.4871.1080.8691.1421.2311.126ST93.5161.4421.0750.8431.1081.1941.092ST103.4071.3971.0410.8161.0731.1571.058ST113.7361.5321.1420.8951.1771.2691.160ST124.9452.0271.5111.1851.5581.6791.536ST133.4071.3971.0410.8161.0731.1571.058ST144.6151.8921.4101.1061.4541.5671.433ST156.2642.5681.9141.5011.9732.1271.945ST166.7032.7482.0481.6062.1122.2762.082ST178.3523.4242.5522.0012.6312.8362.594

In addition, the $RfD_{metal}$ measured in mg/kg/day stands for a maximum acceptable oral reference dose for a typical heavy metal varies for different metals. [Table 2](#t0010){ref-type="table"} presents the values of $RfD_{metal}$ for different metals obtained in this study [@bib9], [@bib10], [@bib15]. Several literatures have established that a risk is very likely when the $HRI_{IN}$ is equal or greater than unity while the probability of a risk not occurring is postulated when $HRI_{IN}$ is less than unity [@bib16], [@bib17], [@bib18], [@bib19]. These values are tabulated in [Table 3a](#t0015){ref-type="table"}, [Table 3b](#t0020){ref-type="table"}, [Table 4a](#t0025){ref-type="table"}, [Table 4b](#t0030){ref-type="table"}, [Table 5a](#t0035){ref-type="table"}, [Table 5b](#t0040){ref-type="table"}, [Table 6a](#t0045){ref-type="table"}, [Table 6b](#t0050){ref-type="table"}, [Table 7a](#t0055){ref-type="table"}, [Table 7b](#t0060){ref-type="table"}(a)--(b) for all the metals obtained in this study.Table 6bHealth Risk Index (HRI) via ingestion pathway for As concentration.Table 6b:**As HRI**~**IN**~**values***Station ID*(6--12 months)(6--11 years)(11--16 years)(16--18 years)(18--21 years)(≥21 years)(\>65 years)ST15.556E+004.141E+003.248E+004.269E+004.602E+001.355E+014.209E+00ST25.556E+004.141E+003.248E+004.269E+004.602E+001.355E+014.209E+00ST37.959E+005.932E+004.652E+006.115E+006.591E+001.941E+016.029E+00ST47.959E+005.932E+004.652E+006.115E+006.591E+001.941E+016.029E+00ST57.358E+005.485E+004.301E+005.654E+006.094E+001.795E+015.574E+00ST67.058E+005.261E+004.125E+005.423E+005.845E+001.722E+015.346E+00ST76.007E+004.477E+003.511E+004.615E+004.975E+001.465E+014.550E+00ST84.956E+003.694E+002.896E+003.808E+004.104E+001.209E+013.754E+00ST94.805E+003.582E+002.809E+003.692E+003.980E+001.172E+013.640E+00ST104.655E+003.470E+002.721E+003.577E+003.855E+001.136E+013.526E+00ST115.106E+003.806E+002.984E+003.923E+004.228E+001.245E+013.868E+00ST126.758E+005.037E+003.950E+005.192E+005.596E+001.648E+015.119E+00ST134.655E+003.470E+002.721E+003.577E+003.855E+001.136E+013.526E+00ST146.307E+004.701E+003.686E+004.846E+005.223E+001.538E+014.778E+00ST158.560E+006.380E+005.003E+006.577E+007.089E+002.088E+016.484E+00ST169.160E+006.828E+005.354E+007.038E+007.586E+002.234E+016.939E+00ST171.141E+018.507E+006.671E+008.769E+009.452E+002.784E+018.645E+00Table 7aAverage daily dose (ADD) via ingestion pathway for Pb concentration.Table 7a**Pb ADD**~**IN**~**values***Station ID*(6--12 months)(6--11 years)(11--16 years)(16--18 years)(18--21 years)(≥21 years)(\>65 years)ST1NDNDNDNDNDNDNDST2NDNDNDNDNDNDNDST3NDNDNDNDNDNDNDST41.0990.4510.3360.2630.3460.3730.341ST50.7690.3150.2350.1840.2420.2610.239ST60.7690.3150.2350.1840.2420.2610.239ST7NDNDNDNDNDNDNDST8NDNDNDNDNDNDNDST9NDNDNDNDNDNDNDST10NDNDNDNDNDNDNDST11NDNDNDNDNDNDNDST12NDNDNDNDNDNDNDST13NDNDNDNDNDNDNDST14NDNDNDNDNDNDNDST15NDNDNDNDNDNDNDST16NDNDNDNDNDNDNDST17NDNDNDNDNDNDNDTable 7bHealth Risk Index (HRI) via ingestion pathway for Pb concentration.Table 7b**Pb HRI**~**IN**~**values***Station ID*(6--12 months)(6--11 years)(11--16 years)(16--18 years)(18--21 years)(≥21 years)(\>65 years)ST1NDNDNDNDNDNDNDST2NDNDNDNDNDNDNDST3NDNDNDNDNDNDNDST43.218E−012.399E−011.881E−012.473E−012.665E−017.849E−012.438E−01ST52.253E−011.679E−011.317E−011.731E−011.865E−015.495E−011.706E−01ST62.253E−011.679E−011.317E−011.731E−011.865E−015.495E−011.706E−01ST7NDNDNDNDNDNDNDST8NDNDNDNDNDNDNDST9NDNDNDNDNDNDNDST10NDNDNDNDNDNDNDST11NDNDNDNDNDNDNDST12NDNDNDNDNDNDNDST13NDNDNDNDNDNDNDST14NDNDNDNDNDNDNDST15NDNDNDNDNDNDNDST16NDNDNDNDNDNDNDST17NDNDNDNDNDNDND
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[^1]: ^\*^NA=Not Applicable.
